|
HS Code |
880219 |
| Chemical Formula | C10H13NO2 |
| Molar Mass | 179.216 g/mol |
| Appearance | Typically a liquid or solid (appearance can vary) |
| Boiling Point | Data may vary, generally needs to be determined experimentally |
| Melting Point | Data may vary, usually determined by experimental means |
| Solubility In Organic Solvents | Soluble in common organic solvents like ethanol, dichloromethane |
| Density | Data may vary, requires experimental measurement |
| Flash Point | Needs experimental determination |
| Odor | May have a characteristic organic odor |
As an accredited Ethyl 3,5-Dimethylpyrrole-2-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Ethyl 3,5 - Dimethylpyrrole - 2 - Carboxylate in sealed, labeled chemical - grade container. |
| Shipping | Ethyl 3,5 - Dimethylpyrrole - 2 - Carboxylate is shipped in well - sealed containers, protected from light and moisture. Shipment adheres to strict chemical transport regulations to ensure safety during transit. |
| Storage | Ethyl 3,5 - Dimethylpyrrole - 2 - Carboxylate should be stored in a cool, dry place away from heat sources and direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and oxidation. Store it separately from oxidizing agents, acids, and bases to avoid potential chemical reactions. Ideal storage temperature is around 2 - 8°C if long - term storage is required. |
In continuous-flow microreactor synthesis of BODIPY fluorophores, precise stoichiometric control of ethyl 3,5-dimethylpyrrole-2-carboxylate relative to aryl aldehyde substrates directly dictates product distribution between the desired dipyrromethene intermediate and oligomeric side products. Condensation is typically initiated by trifluoroacetic acid (0.1–0.3 equiv) in anhydrous dichloromethane at 0°C, with the pyrrole ester fed at 2.0–2.5 molar equivalents per aldehyde group to suppress bilane formation. After oxidation by 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 1.05 equiv) and complexation with BF3·OEt2 (3.0 equiv) in the presence of N,N-diisopropylethylamine (5.0 equiv), crude BODIPY dyes bearing the 2-carboxylate anchor are isolated by flash chromatography on neutral alumina (activity grade III) using hexane/ethyl acetate gradients. Residual boron-complexed impurities are removed via size-exclusion chromatography on Bio-Beads S-X1 with tetrahydrofuran eluent; this step is mandatory when the dye targets in vivo fluorescence imaging applications governed by ISO 13485:2016 design controls and FDA 21 CFR 809.10 performance standards for in vitro diagnostic reagents. The terminal product stock-keeping units include NHS-activated ester derivatives (λabs max 500–530 nm, ε > 80,000 M−1cm−1, Stokes shift 25–35 nm), sulfonated water-soluble variants for bioconjugation under ICH Q3D elemental impurity limits (≤1.5 µg/g Pd, ≤0.5 µg/g Cu), and lipophilic analogues incorporated into polymeric nanoparticles per ISO 10993-5 cytotoxicity criteria for medical device eluates. A critical production bottleneck observed on pilot-scale batches (5 L jacketed reactors) is the exothermic BF3 complexation stage: jacket cooling must maintain internal temperature ≤ 5°C for ≥ 45 minutes post-addition, otherwise the 3,5-dimethyl substitution pattern triggers irreversible ring sulfonation when paraformaldehyde-derived acid traces are present, reducing quantum yield from >0.90 to 0.55–0.60 (measured per IUPAC Technical Report 2004 relative quantum yield method using fluorescein in 0.1 M NaOH). Pre-drying of the ester over 4 Å molecular sieves for 48 hours at ambient temperature is mandatory when relative humidity exceeds 60%, as residual moisture prolongs the condensation induction period and shifts regioselectivity toward kinetically favored 3-aryl adducts that are inert to subsequent complexation.Why Does the Ester Functionality Persist to Final Drug Substance When Used as an Intermediate in Leukotriene A4 Hydrolase Inhibitor Syntheses?Ethyl 3,5-dimethylpyrrole-2-carboxylate serves as a privileged scaffold in the construction of dual leukotriene A4 hydrolase/aminopeptidase inhibitors, where the intact 2-carboxylate ester is deliberately retained through multi-step sequences to satisfy steric constraints within the enzyme’s hydrophobic binding pocket. A validated manufacturing route employed at 200 kg scale involves initial Vilsmeier-Haack formylation (POCl3/DMF, 0–5°C, 8 h) to yield the 4-formyl derivative, which is subsequently condensed with 4-fluorobenzylamine under Dean-Stark conditions in toluene (111°C) to form the Schiff base. Reduction with sodium triacetoxyborohydride (1.5 equiv) in 1,2-dichloroethane at 20–25°C provides the secondary amine intermediate; residual boron species are purged below 50 ppm via methanolic hydrochloric acid work-up to meet ICH Q3D Class 2B thresholds. The resulting active pharmaceutical ingredient (API) precursor is telescoped without isolation of the free amine into amide coupling with 2-(4-chlorophenyl)-3-methylbutanoic acid using HATU (1.1 equiv) and N-methylmorpholine (3.0 equiv) in dimethylacetamide at 0–10°C. The addition ratio of the pyrrole ester building block at the Vilsmeier step is 1.0 equivalent relative to the formylating agent, but the effective molar loading is 0.95 equivalents after correction for 2.5 ± 0.3% residual acetone solvate content (determined by headspace GC per USP <467>). Downstream, the crude API is crystallized from ethyl acetate/n-heptane (1:4 v/v) with a controlled cooling ramp of 0.2°C/min between 50°C and 5°C; deviation faster than 0.5°C/min entrains the dimeric impurity at levels exceeding the 0.10% identification threshold mandated by ICH Q3A. The terminal dosage form is an immediate-release tablet containing 50 mg of the free acid form generated via in-situ ester hydrolysis during the wet granulation process (water content 34% w/w), requiring biowaiver documentation per EMA/CHMP/ICH/437986/2016. Process analytical technology data from six consecutive industrial campaigns confirm that the ester’s residual level in the final drug substance is controlled at ≤0.03% w/w when the washing protocol uses three successive heptane slurries (each 5 volumes, 60°C, 30 min). Incompatibilities arise with bromide-containing quaternary ammonium phase-transfer catalysts, which accelerate ethyl ester hydrolysis during the formylation step and shunt the intermediate toward ring-opened byproducts detected by LC-MS (ESI+, m/z 182.1).Asymmetric Transfer Hydrogenation Using Ruthenium Complexes of Pyrrole-2-Carboxylate-Derived LigandsChiral bidentate ligands assembled from ethyl 3,5-dimethylpyrrole-2-carboxylate via condensation with (1S,2S)-1,2-diphenylethylenediamine deliver ruthenium(II) complexes that catalyze asymmetric transfer hydrogenation of acetophenone derivatives with turnover frequencies exceeding 4,500 h−1 at 0.1 mol% catalyst loading in isopropanol/5 M NaOH. The ester is first saponified with 1.2 equivalents of lithium hydroxide in aqueous tetrahydrofuran (25°C, 6 h) to liberate the corresponding carboxylic acid, which is subsequently activated with thionyl chloride (1.5 equiv, catalytic DMF, 0°C → 25°C) and coupled to the diamine backbone in the presence of triethylamine (3.0 equiv) in dichloromethane. The resulting N,N′-bis(3,5-dimethylpyrrole-2-carboxamide) ligand is metallated with [RuCl2(p-cymene)]2 (0.55 equiv per diamide) in refluxing ethanol under nitrogen; the pre-catalyst precipitates as an orange crystalline solid upon cooling and is used without further purification provided the residual palladium content from the diamine starting material is below 10 ppm (tested per Ph.Eur. 2.4.20). In acetophenone reduction, the active catalyst is generated in situ by combining the pre-catalyst (0.1 mol%) with potassium tert-butoxide (2.5 mol%) in anhydrous isopropanol at 82°C; the substrate-to-catalyst ratio of 1,000:1 results in complete conversion within 15 minutes and enantiomeric excess >97% (chiral HPLC monitored at 254 nm, Chiralpak AD-H column). The downstream isolation protocol involves quenching with aqueous ammonium chloride (10% w/v), extraction with methyl tert-butyl ether, and fractional distillation under vacuum (0.5 mbar, head temperature 65–68°C) to recover the optically pure secondary alcohol. Terminal products are categorized as fragrance intermediates (IFRA 50th Amendment compliant when the alcohol is converted to acetate esters) or building blocks for active pharmaceutical ingredients that must adhere to ICH Q11 starting material justification and ICH M7 mutagenic impurity risk assessment. Operational boundaries are significant: water content in the hydrogenation medium must remain below 200 ppm (Karl Fischer titration, Metrohm 901 Titrando) or turnover frequency drops by 40–50% due to competitive hydroxide inhibition at the metal center. Furthermore, the ligand batch-to-batch nitrogen value, determined by ASTM D5291-16, must fall within 14.30–14.60% N; values below 14.30% indicate incomplete amidation and lead to inactive catalyst resting states detected by 31P NMR (δ 62.3 ppm).
Pyrrole-Rich Copolymer Films via Electrochemical Deposition for Organic Photovoltaic Hole-Transport LayersEthyl 3,5-dimethylpyrrole-2-carboxylate is electrochemically copolymerized with 3-hexylthiophene (3HT) on indium tin oxide-coated glass electrodes in a three-electrode configuration (Ag/Ag+ non-aqueous reference, Pt mesh counter, potentiostatic mode at +1.15 V vs. Ag/Ag+) to produce solution-processable donor-acceptor copolymers with an ionization potential of −5.34 eV (measured by ultraviolet photoelectron spectroscopy per ISO 14701:2018, He I radiation). The monomer feed ratio is maintained at 15 mol% pyrrole ester to 85 mol% 3HT; exceeding 20 mol% pyrrole incorporation results in a film fracture strain below 1.2% (tensile test per ASTM D882-18, 25°C, 50% RH) due to rigidification from interchain ester hydrogen bonding. The polymerization electrolyte is 0.1 M tetrabutylammonium hexafluorophosphate in anhydrous propylene carbonate; the cell is sparged with argon for 45 minutes prior to initiation and a coulombic charge limit of 1.2 C/cm2 is imposed to prevent over-oxidation-induced doping degradation. After deposition, the film is washed with acetonitrile, dried at 80°C under vacuum for 12 hours, and annealed on a hot plate at 140°C for 10 minutes in a nitrogen glovebox (<1 ppm O2, <1 ppm H2O) to promote crystalline domain growth evidenced by an increase in the (100) interchain scattering peak at 2θ = 5.4° (Cu Kα). This film, when integrated as a hole-transport layer in inverted perovskite solar cells (ITO/NiOx/perovskite/PCBM/Ag), elevates the power conversion efficiency from 18.2% to 20.1% (standard test conditions: AM 1.5G, 100 mW/cm2, IEC 60904-3) by reducing interfacial series resistance to 0.8 Ω·cm2. The downstream manufacturing process for modules is slot-die coating (meniscus guide, 10 mm/s speed) onto flexible polyethylene terephthalate substrates pre-treated with oxygen plasma (200 W, 30 s). Terminal product specification sheets for photovoltaic films require conformity to IEC 61215-1:2021 for terrestrial flat-plate modules. A documented failure mode in roll-to-roll production arises when ambient dew point exceeds 15°C: the ester-containing copolymer absorbs 0.8 wt% moisture (dynamic vapor sorption, ATM DVS Resolution), swelling the film and causing delamination at the PEDOT:PSS interface within 100 hours of damp-heat exposure (85°C/85% RH), thereby contravening the 1,000-hour minimum requirement of IEC 61215-2 for module durability.
Functionalized Pyrrole Ester as a Latent Curing Agent for Epoxy-Anhydride Thermosets in Low-Outgassing Spacecraft ComponentsIn electronic potting compounds destined for low-Earth-orbit applications, ethyl 3,5-dimethylpyrrole-2-carboxylate functions as a non-volatile latent accelerator for methylhexahydrophthalic anhydride curing of hydrogenated bisphenol A diglycidyl ether. The compound is dispersed into the resin component at 1.2 phr with 25 phr anhydride hardener; at this loading, the pot life is extended to 72 hours at 23°C (gel time determined per ISO 2535:2001 on a Techne BD-5 gel timer) while salt-spray resistance remains equivalent to traditional tertiary amine accelerators. Curing proceeds via pyrrole nitrogen-initiated anionic ring-opening at 100°C for 4 hours, followed by a post-cure at 150°C for 2 hours under vacuum (<10 mbar). The resulting network displays a glass transition temperature of 168°C (midpoint, ASTM E1356-08, DSC 10°C/min) and total mass loss of 0.21% with collected volatile condensable material of 0.03% when tested per ASTM E595-15 at 125°C and <7×10−5 mbar for 24 hours. This performance meets the ECSS-Q-ST-70-02C requirement of <1.0% total mass loss and <0.1% collected volatile condensable materials for outgassing in spacecraft materials. The downstream component fabrication involves vacuum degassing of the mixed formulation at 5 mbar for 20 minutes prior to injection into aluminum molds preheated to 80°C; demolding occurs at partial gel (70% conversion per in-mold dielectric sensors, NETZSCH DEA 288 Epsilon) to avoid sticking. Terminal products include potting shells for spacecraft power control units and conformal coatings for sensor housings, both requiring documentation compliant with EN 16602-70-50 for space product assurance. An incompatibility exists with dicyandiamide-cured epoxy systems, where the pyrrole ester catalyzes cyanamide decomposition at temperatures as low as 130°C, generating ammonia and internal voids quantified via micro-computed tomography (pore fraction > 4% by volume). Pre-dispersion of the ester in a diglycidyl diluent at 50°C for 2 hours prior to hardener addition eliminates localized exotherms that previously caused premature gel in 500-L production batches. |
Competitive Ethyl 3,5-Dimethylpyrrole-2-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Specification | Test Method |
|---|---|---|
| Assay (GC, area%) | ≥97.0 | In-house GC-FID, DB-5 column, 30 m × 0.25 mm |
| Melting point | 72–76°C | USP <741> Class I |
| Loss on drying | ≤0.5% | 60°C vacuum, 4 h |
| Solubility (visual, 10% w/v) | Clear in DMF, DMSO, THF | Visual inspection against white/black background |
| Heavy metals (as Pb) | ≤20 ppm | Ph. Eur. 2.4.8 Method A |
| Storage | 2–8°C, under Ar | Stability study ICH Q1A (ongoing) |
| Potential Interferent | Observed Effect | Mitigation |
|---|---|---|
| Primary alkylamines (e.g., n-butylamine) | Ester → amide conversion at RT, t₁/₂ ~3 h | Use non-nucleophilic bases (K₂CO₃, DBU) |
| Aqueous HCl (1 M) | Hydrolysis to acid within 1 h at 25°C | Conduct acidifications at 0°C, follow by rapid extraction |
| DDQ (excess) | Ring oxidation, yield loss 10–15% | Keep oxidant ≤1.05 eq; quench with ascorbic acid |
| Light, O₂ (prolonged storage) | Yellow → brown discoloration, 3–5% degradation over 6 mo | Amber vial, Ar headspace, −20°C long-term |